IgA nephropathy (patient information)

Revision as of 20:50, 25 March 2010 by Apalmer (talk | contribs)
Jump to navigation Jump to search

For the WikiDoc page for this topic, click here

WikiDoc Resources for IgA nephropathy (patient information)

Articles

Most recent articles on IgA nephropathy (patient information)

Most cited articles on IgA nephropathy (patient information)

Review articles on IgA nephropathy (patient information)

Articles on IgA nephropathy (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on IgA nephropathy (patient information)

Images of IgA nephropathy (patient information)

Photos of IgA nephropathy (patient information)

Podcasts & MP3s on IgA nephropathy (patient information)

Videos on IgA nephropathy (patient information)

Evidence Based Medicine

Cochrane Collaboration on IgA nephropathy (patient information)

Bandolier on IgA nephropathy (patient information)

TRIP on IgA nephropathy (patient information)

Clinical Trials

Ongoing Trials on IgA nephropathy (patient information) at Clinical Trials.gov

Trial results on IgA nephropathy (patient information)

Clinical Trials on IgA nephropathy (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on IgA nephropathy (patient information)

NICE Guidance on IgA nephropathy (patient information)

NHS PRODIGY Guidance

FDA on IgA nephropathy (patient information)

CDC on IgA nephropathy (patient information)

Books

Books on IgA nephropathy (patient information)

News

IgA nephropathy (patient information) in the news

Be alerted to news on IgA nephropathy (patient information)

News trends on IgA nephropathy (patient information)

Commentary

Blogs on IgA nephropathy (patient information)

Definitions

Definitions of IgA nephropathy (patient information)

Patient Resources / Community

Patient resources on IgA nephropathy (patient information)

Discussion groups on IgA nephropathy (patient information)

Patient Handouts on IgA nephropathy (patient information)

Directions to Hospitals Treating IgA nephropathy (patient information)

Risk calculators and risk factors for IgA nephropathy (patient information)

Healthcare Provider Resources

Symptoms of IgA nephropathy (patient information)

Causes & Risk Factors for IgA nephropathy (patient information)

Diagnostic studies for IgA nephropathy (patient information)

Treatment of IgA nephropathy (patient information)

Continuing Medical Education (CME)

CME Programs on IgA nephropathy (patient information)

International

IgA nephropathy (patient information) en Espanol

IgA nephropathy (patient information) en Francais

Business

IgA nephropathy (patient information) in the Marketplace

Patents on IgA nephropathy (patient information)

Experimental / Informatics

List of terms related to IgA nephropathy (patient information)

Editor-in-Chief: Erin E. Lord

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

What is IgA nephropathy?

Nephropathy refers to damage, disease , or other abnormalities of the kidney. IgA nephropathy is a kidney disorder in which antibodies to a protein called IgA build up in kidney tissue.

What are the symptoms of IgA nephropathy?

There may be no symptoms for many years.

Symptoms include:

  • Bloody urine that starts during or soon after a respiratory infection
  • Repeated episodes of dark or bloody urine
  • Hand and feet swelling
  • Symptoms of chronic kidney disease

What are the causes of IgA nephropathy?

IgA is a protein that helps the body fight infections. IgA nephropathy (Berger's disease) occurs when too much of this protein is deposited in the kidneys. IgA builds up inside the small blood vessels of the kidney. Structures in the kidney called glomeruli become inflamed.

IgA nephropathy (Berger's disease) is a form of mesangial proliferative nephritis.

The disorder can appear suddenly (acute), or progress slowly over many years (chronic glomerulonephritis).

Risk factors include:

  • A personal or family history of IgA nephropathy or Henoch Schonlein purpura, a form of vasculitis that affects many parts of the body
  • Caucasian or Asian ethnicity

Who is at risk for IgA nephropathy?

IgA nephropathy can occur in persons of all ages, but most often affects males in their teens to late 30s. IgA nephropathy is a genetic disorder, so anyone with a family history of the disorder is at risk.

How to know you have IgA nephropathy?

IgA nephropathy usually is discovered after one or more episodes of dark or bloody urine in a person with no other symptoms of kidney disorder.

There are no specific changes seen during a physical examination. Occasionally, blood pressure may be high or swelling of the body may be present.

Tests include:

  • Creatinine and blood urea nitrogen (BUN) to measure kidney function
  • Urinalysis will show blood and protein in the urine
  • Kidney biopsy confirms the diagnosis
  • Urine immunoelectrophoresis

When to seek urgent medical care

Call your health care provider if you have bloody urine or if your urine output decreases.

Treatment options

The goal of treatment is to relieve symptoms and prevent or delay chronic renal failure.

Medicines may be given to control high blood pressure and swelling (edema). Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are used. Controlling blood pressure is the most important measure to delay kidney damage.

Corticosteroids, other immunosuppressive drugs, and fish oil have also been used to treat this disorder.

Salt and fluids may be restricted to control swelling. A low to moderateprotein diet may be recommended in some cases.

Some people will need to take medicines to lower their cholesterol.

Eventually, many patients must be treated for chronic kidney disease.

Where to find medical care for IgA nephropathy

Directions to Hospitals Treating IgA nephropathy

What to expect (Outlook/Prognosis)

IgA nephropathy progresses slowly. In many cases, it does not progress at all. High blood pressure, large quantities of protein in the urine, and increased BUN or creatinine levels (blood tests that reflect kidney functioning) indicate a higher risk for progression of the disorder.

About 25% of adults with IgA nephropathy develop end-stage kidney failure within about 25 years.

Possible complications

Sources

http://www.nlm.nih.gov/medlineplus/ency/article/000466.htm

Template:SIB Template:WH Template:WS